Carelog, founded in 2023, is positioned at the intersection of AI and Healthcare, focusing on the development of deep learning algorithms tailored for electrocardiogram signals. With the guiding philosophy of "Innovation begins at heart," the company's platform enables early diagnosis and efficient management of a range of clinical conditions, addressing critical needs in the healthcare industry.
Headquartered in the United States, Carelog has already attracted investor attention, securing a $100.00K Pre-Seed Round funding on June 4, 2024, led by Forum Ventures. This investment underscores the potential of Carelog in pioneering technological advancements within cardiac healthcare diagnostics.
Given the increasing reliance on AI solutions for medical diagnostics, Carelog offers a compelling opportunity for investors seeking exposure in cutting-edge health tech innovations.